Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-03-26Observational Post-Marketing Safety Surveillance Registry of Enbrel (Etanercept) for Treatment of Psoriasis
-
CLINICAL_TRIALS study record update · 2014-03-20An Open Label, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g
-
CLINICAL_TRIALS study record update · 2014-03-18Long-term Safety Follow-up of REMICADE (RESULTS)
-
CLINICAL_TRIALS study record update · 2014-03-17A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Infliximab in the Treatment of Chinese Subjects With Moderate to Severe Plaque-type Psoriasis
-
CLINICAL_TRIALS study record update · 2014-03-11Efficacy and Safety of LEO 90105 Ointment (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis Vulgaris
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-03-04A Phase IIIb, Open-Label, Multicenter Study to Evaluate the Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults With Moderate to Severe Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies or Have Recently Transitioned From Systemic Therapies
-
CLINICAL_TRIALS study record update · 2014-02-26Prospective Post Marketing Surveillance To Evaluate The Safety And Efficacy Of Etanercept Under Usual Care Settings In Patients With Psoriatic Arthritis (Psa) Treated By Dermatologists
-
CLINICAL_TRIALS study record update · 2014-02-26Prospective Post Marketing Surveillance to Evaluate the Safety and Efficacy of Etanercept Under Usual Care Settings in Patients With Psoriatic Arthritis (PsA) Treated by Rheumatologists
-
CLINICAL_TRIALS study record update · 2014-02-21[E S] A Greek, Post-marketing, Observational Study of the quAlity of Life in Patients With Psoriasis Treated With Adalimumab - GOAL Study
-
CLINICAL_TRIALS study record update · 2014-02-12Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
-
CLINICAL_TRIALS study record update · 2013-12-16The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2013-12-12A Phase 2, Single-Arm Study to Evaluate the Safety and Pharmacokinetics of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis [ISN 0485-CL-0004]
-
CLINICAL_TRIALS study record update · 2013-12-11Assessment and Tracking of Long-term Alefacept (LFA-3/IgG1 Fusion Protein) Safety (ATLAS)
-
CLINICAL_TRIALS study record update · 2013-11-19A Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Subjects With Moderate to Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2013-11-07A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Treating Scalp Involvement in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2013-11-01Prospective, Randomized Half-side Study on the Efficacy of UVB-311nm Phototherapy in Patients With Psoriasis After Partial Remission to Treatment With Adalimumab
-
CLINICAL_TRIALS study record update · 2013-11-01Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single Rising, Open-label Doses of AbGn-168 Administered by Intravenous Infusion (1 Mcg/kg, 5 Mcg/kg, 25 Mcg/kg, 125 Mcg/kg, 625 Mcg/kg, 3 mg/kg, or 10 mg/kg) or Subcutaneous Injection (625 Mcg/kg) to Patients With Chronic Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2013-10-31A Randomized Study to Evaluate the Efficacy and Safety of Adding Topical Therapy to Etanercept in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2013-10-08Special Investigation (All Cases Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis)
-
CLINICAL_TRIALS study record update · 2013-09-24Role of Conditioning in the Pharmacotherapy of Psoriasis
-
CLINICAL_TRIALS study record update · 2013-08-20Post-Marketing Surveillance of Humira Injection in Korean Patients Under the "New-Drug Re-examination"
-
CLINICAL_TRIALS study record update · 2013-08-19ClinicalTrials.gov study NCT01844973
-
CLINICAL_TRIALS study record update · 2013-08-15A Randomized, Double-blind, Double-dummy, Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy After Twelve Weeks of Treatment, Compared to Placebo and Etanercept, and to Assess the Safety, Tolerability and Long-term Efficacy up to One Year in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis.
-
CLINICAL_TRIALS study record update · 2013-08-12A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adding Methotrexate to Etanercept in Subjects With Moderate to Severe Plaque Psoriasis
-
CLINICAL_TRIALS study record update · 2013-08-12Post Marketing Surveillance of Remicade in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Patients